WO2003055983A2
(en)
*
|
2001-12-21 |
2003-07-10 |
The Salk Institute For Biological Studies |
Targeted retrograde gene delivery to motor neurons
|
CN1972709A
(zh)
*
|
2004-06-21 |
2007-05-30 |
阿姆斯特丹大学医学院 |
非酒精性脂肪性肝炎的治疗方法
|
US9238150B2
(en)
|
2005-07-22 |
2016-01-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optical tissue interface method and apparatus for stimulating cells
|
US20070053996A1
(en)
|
2005-07-22 |
2007-03-08 |
Boyden Edward S |
Light-activated cation channel and uses thereof
|
US8926959B2
(en)
*
|
2005-07-22 |
2015-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
US20090093403A1
(en)
|
2007-03-01 |
2009-04-09 |
Feng Zhang |
Systems, methods and compositions for optical stimulation of target cells
|
US10052497B2
(en)
|
2005-07-22 |
2018-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
US9274099B2
(en)
|
2005-07-22 |
2016-03-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
|
US20090191597A1
(en)
*
|
2006-01-20 |
2009-07-30 |
Asklepios Biopharmaceutical, Inc. |
Enhanced production of infectious parvovirus vectors in insect cells
|
EP1994043A4
(de)
|
2006-02-10 |
2009-05-20 |
Univ Cincinnati |
Phosphatasehemmer-protein 1 als regulator der herzfunktion
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
JP2009534394A
(ja)
*
|
2006-04-21 |
2009-09-24 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
結合組織障害の治療
|
WO2007146046A2
(en)
*
|
2006-06-07 |
2007-12-21 |
Genzyme Corporation |
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
|
EP2037892B1
(de)
|
2006-06-19 |
2015-03-18 |
Asklepios Biopharmaceutical, Inc. |
Modifizierte fatkor-viii- und faktor-ix-gene und vektoren für gentherapie
|
WO2008086470A1
(en)
|
2007-01-10 |
2008-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
WO2008101128A1
(en)
|
2007-02-14 |
2008-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
System, method and applications involving identification of biological circuits such as neurological characteristics
|
EP2019143A1
(de)
|
2007-07-23 |
2009-01-28 |
Genethon |
Gentherapie des ZNS mit peripher verabreichten AAV-Vektoren
|
EP2058401A1
(de)
|
2007-10-05 |
2009-05-13 |
Genethon |
Weitverbreitete Genverabreichung an Motorneuronen unter Verwendung einer peripheren Injektion von AAV-Vektoren
|
US10434327B2
(en)
|
2007-10-31 |
2019-10-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Implantable optical stimulators
|
US10035027B2
(en)
|
2007-10-31 |
2018-07-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Device and method for ultrasonic neuromodulation via stereotactic frame based technique
|
WO2009105135A1
(en)
|
2008-02-19 |
2009-08-27 |
Celladon Corporation |
Compositions for enhanced uptake of viral vectors in the myocardium
|
WO2009131837A2
(en)
|
2008-04-23 |
2009-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University. |
Systems, methods and compositions for optical stimulation of target cells
|
BRPI0913285A2
(pt)
|
2008-05-29 |
2018-10-16 |
Univ Leland Stanford Junior |
linhagem celular, sistema e método para controle ótico de mensageiros secundários
|
BRPI0915583A2
(pt)
|
2008-06-17 |
2016-01-26 |
Univ Leland Stanford Junior |
aparelho e métodos para controle do desenvolvimento celular
|
US9101759B2
(en)
|
2008-07-08 |
2015-08-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Materials and approaches for optical stimulation of the peripheral nervous system
|
NZ602416A
(en)
|
2008-11-14 |
2014-08-29 |
Univ Leland Stanford Junior |
Optically-based stimulation of target cells and modifications thereto
|
WO2010093784A2
(en)
|
2009-02-11 |
2010-08-19 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
EP2287323A1
(de)
|
2009-07-31 |
2011-02-23 |
Association Institut de Myologie |
Weitverbreitete Genverabreichung an die Netzhaut mithilfe der systemischen Verabreichung von AAV-Vektoren
|
EP2524037B1
(de)
|
2010-01-12 |
2018-05-16 |
The University Of North Carolina At Chapel Hill |
Restriktive umgekehrte endverstärkungen für virusvektoren
|
EP2547762B1
(de)
|
2010-03-17 |
2018-04-25 |
The Board of Trustees of the Leland Stanford Junior University |
Lichtempfindliche ionendurchgangsmoleküle
|
US20130023033A1
(en)
|
2010-03-29 |
2013-01-24 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
CA2805170C
(en)
|
2010-07-12 |
2021-09-21 |
Fatima Bosch Tubert |
Gene therapy composition for use in diabetes treatment
|
ES2716819T3
(es)
|
2010-11-05 |
2019-06-17 |
Univ Leland Stanford Junior |
Opsinas quiméricas activadas por luz y métodos de uso de las mismas
|
JP6355335B2
(ja)
|
2010-11-05 |
2018-07-11 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
報酬関連行動の光遺伝学的制御
|
CN106422081B
(zh)
|
2010-11-05 |
2019-06-21 |
斯坦福大学托管董事会 |
用于光遗传学方法的光的上转换
|
CA3056186A1
(en)
|
2010-11-05 |
2012-05-10 |
Board Of Trustees Of The Leland Stanford Junior University |
Optically-controlled cns dysfunction
|
CA2816990A1
(en)
|
2010-11-05 |
2012-05-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Stabilized step function opsin proteins and methods of using the same
|
AU2011323228B2
(en)
|
2010-11-05 |
2016-11-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Control and characterization of memory function
|
US8696722B2
(en)
|
2010-11-22 |
2014-04-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic magnetic resonance imaging
|
US9409953B2
(en)
|
2011-02-10 |
2016-08-09 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
CA2859364C
(en)
|
2011-12-16 |
2019-05-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Opsin polypeptides and methods of use thereof
|
ES2628006T3
(es)
|
2012-02-21 |
2017-08-01 |
Circuit Therapeutics, Inc. |
Composiciones para el tratamiento de trastornos neurogénicos del suelo pélvico
|
CA2868507A1
(en)
*
|
2012-04-02 |
2013-10-10 |
Cytokinetics, Inc. |
Methods for improving diaphragm function
|
EP2847337A4
(de)
|
2012-05-09 |
2016-04-27 |
Univ Oregon Health & Science |
Adeno-assoziierte virenplasmide und vektoren
|
EP2692868A1
(de)
|
2012-08-02 |
2014-02-05 |
Universitat Autònoma De Barcelona |
Adenoassoziierte virale (AAV) Vektoren für die Transduktion von Fettgewebe
|
CN104797593B
(zh)
|
2012-09-28 |
2020-05-08 |
北卡罗来纳-查佩尔山大学 |
靶向少突胶质细胞的aav载体
|
WO2014144229A1
(en)
|
2013-03-15 |
2014-09-18 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav vectors
|
JP6594854B2
(ja)
|
2013-03-15 |
2019-10-23 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
行動状態の光遺伝学的制御方法
|
EP2970966A4
(de)
|
2013-03-15 |
2016-10-26 |
Univ North Carolina |
Synthetische adenoassoziierte virusinvertierte endwiederholungssequenzen
|
US9636380B2
(en)
|
2013-03-15 |
2017-05-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic control of inputs to the ventral tegmental area
|
AU2014260101B2
(en)
|
2013-04-29 |
2018-07-26 |
Humboldt-Universitat Zu Berlin |
Devices, systems and methods for optogenetic modulation of action potentials in target cells
|
EP3567112A1
(de)
|
2013-06-13 |
2019-11-13 |
Translate Bio, Inc. |
Virenproduktion auf messenger-rna-basis
|
CA2921221A1
(en)
|
2013-08-14 |
2015-02-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for controlling pain
|
MX2016011686A
(es)
|
2014-03-09 |
2016-11-07 |
Univ Pennsylvania |
Composiciones utiles en el tratamiento de deficiencia de la ornitina transcarbamilasa (otc).
|
ES2876409T3
(es)
|
2014-04-25 |
2021-11-12 |
Univ Pennsylvania |
Variantes del RLBD y su uso en composiciones para reducir los niveles de colesterol
|
US10780182B2
(en)
|
2014-04-25 |
2020-09-22 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for treating metastatic breast cancer and other cancers in the brain
|
KR102550926B1
(ko)
|
2014-05-13 |
2023-07-05 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
이중 항체 구축물을 발현하는 aav를 포함하는 조성물 및 이들의 용도
|
WO2016041588A1
(en)
|
2014-09-16 |
2016-03-24 |
Universitat Autònoma De Barcelona |
Adeno-associated viral vectors for the gene therapy of metabolic diseases
|
WO2016081811A1
(en)
|
2014-11-21 |
2016-05-26 |
The University Of North Carolina At Chapel Hill |
Aav vectors targeted to the central nervous system
|
CA2974235A1
(en)
|
2015-01-07 |
2016-07-14 |
Universitat Autonoma De Barcelona |
Single-vector gene construct comprising insulin and glucokinase genes
|
AU2016206624B2
(en)
|
2015-01-14 |
2020-08-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
AU2016215124B2
(en)
|
2015-02-06 |
2020-08-06 |
The University Of North Carolina At Chapel Hill |
Optimized human clotting Factor VIII gene expression cassettes and their use
|
JP6929791B2
(ja)
|
2015-02-09 |
2021-09-01 |
デューク ユニバーシティ |
エピゲノム編集のための組成物および方法
|
WO2016134300A1
(en)
|
2015-02-20 |
2016-08-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for attenuated chlamydia as vaccine and vector
|
US20180110877A1
(en)
|
2015-04-27 |
2018-04-26 |
The Trustees Of The University Of Pennsylvania |
DUAL AAV VECTOR SYSTEM FOR CRISPR/Cas9 MEDIATED CORRECTION OF HUMAN DISEASE
|
WO2016200543A2
(en)
|
2015-05-13 |
2016-12-15 |
The Trustees Of The University Of Pennsylvania |
Aav-mediated expression of anti-inluenza antibodies and methods of use thereof
|
US10568516B2
(en)
|
2015-06-22 |
2020-02-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and devices for imaging and/or optogenetic control of light-responsive neurons
|
US10676735B2
(en)
|
2015-07-22 |
2020-06-09 |
Duke University |
High-throughput screening of regulatory element function with epigenome editing technologies
|
US20180230488A1
(en)
|
2015-08-06 |
2018-08-16 |
The Trustees Of The University Of Pennsylvania |
Glp-1 and use thereof in compositions for treating metabolic diseases
|
IL288662B2
(en)
|
2015-08-25 |
2023-09-01 |
Univ Duke |
Preparations and methods for improving specificity in genomic engineering using RNA-guided endonucleases
|
US11117942B2
(en)
|
2015-08-31 |
2021-09-14 |
The Trustees Of The University Of Pennsylvania |
AAV-EPO for treating companion animals
|
CN115976105A
(zh)
|
2015-09-24 |
2023-04-18 |
宾夕法尼亚州大学信托人 |
用于治疗补体介导的疾病的组合物和方法
|
ES2865487T3
(es)
|
2015-09-28 |
2021-10-15 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para vectores virales que evaden los anticuerpos
|
WO2017062750A1
(en)
|
2015-10-09 |
2017-04-13 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods useful in treating stargardt's disease and other ocular disorders
|
EP3362571A4
(de)
|
2015-10-13 |
2019-07-10 |
Duke University |
Genom-engineering mit typ-i-crispr-systemen in eukaryotischen zellen
|
BR112018008407A2
(pt)
|
2015-10-28 |
2018-11-27 |
Univ Pennsylvania |
administração intratecal de vetores virais adenoassociados para terapia genética
|
IL259850B2
(en)
|
2015-12-11 |
2023-11-01 |
Univ Pennsylvania |
Gene therapy for the treatment of familial hypercholesterolemia
|
MX2018007230A
(es)
|
2015-12-14 |
2018-11-09 |
Univ Pennsylvania |
Terapia genica para trastornos oculares.
|
AU2016370590B2
(en)
|
2015-12-14 |
2023-11-02 |
The Trustees Of The University Of Pennsylvania |
Composition for treatment of Crigler-Najjar syndrome
|
CA3011943A1
(en)
|
2016-02-22 |
2017-08-31 |
The University Of North Carolina At Chapel Hill |
Aav-idua vector for treatment of mps i-associated blindness
|
RU2764919C2
(ru)
|
2016-06-13 |
2022-01-24 |
Дзе Юниверсити Оф Норт Каролина Эт Чепел Хилл |
Оптимизированные гены и экспрессионные кассеты cln1, и их применение
|
CA2971303A1
(en)
|
2016-06-21 |
2017-12-21 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
RU2764920C2
(ru)
|
2016-07-08 |
2022-01-24 |
Зе Трастис Оф Зе Юниверсити Оф Пенсильвания |
Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12
|
WO2018022511A1
(en)
|
2016-07-25 |
2018-02-01 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereof
|
US11866480B2
(en)
|
2016-07-26 |
2024-01-09 |
The University Of North Carolina At Chapel Hill |
Vector-mediated immune tolerance in the eye
|
ES2931960T3
(es)
|
2016-12-01 |
2023-01-05 |
Inst Nat Sante Rech Med |
Composiciones farmacéuticas para el tratamiento de enfermedades degenerativas retinianas
|
EP3595688A4
(de)
|
2017-02-20 |
2020-12-30 |
The Trustees Of The University Of Pennsylvania |
Gentherapie zur behandlung familiärer hypercholesterinämie
|
UY37620A
(es)
|
2017-02-28 |
2018-08-31 |
Univ Pennsylvania |
Vacunas contra la gripe mediadas por aav novedosas
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
SI3589730T1
(sl)
|
2017-02-28 |
2024-04-30 |
The Trustees Of The University Of Pennsylvania |
Adeno-povezan virus (AAV) clade F vektor in njihova uporaba
|
AU2018228881B2
(en)
|
2017-03-01 |
2024-01-25 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for ocular disorders
|
ES2966692T3
(es)
|
2017-03-15 |
2024-04-23 |
Univ North Carolina Chapel Hill |
Vectores de virus adenoasociados poliploides y métodos de fabricación y uso de los mismos
|
US11294165B2
(en)
|
2017-03-30 |
2022-04-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
|
EP3634986A4
(de)
|
2017-04-24 |
2021-09-08 |
The Trustees of The University of Pennsylvania |
Gentherapie für augenerkrankungen
|
AU2018265531A1
(en)
|
2017-05-11 |
2019-11-14 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for neuronal ceroid lipofuscinoses
|
WO2018215613A1
(en)
|
2017-05-24 |
2018-11-29 |
Universitat Autonoma De Barcelona |
Viral expression construct comprising a fibroblast growth factor 21 (fgf21) coding sequence
|
US11793887B2
(en)
|
2017-05-31 |
2023-10-24 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treating peroxisomal disorders
|
US11827898B2
(en)
|
2017-06-14 |
2023-11-28 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for ocular disorders
|
RU2020118342A
(ru)
|
2017-11-07 |
2021-12-08 |
Дзе Юниверсити Оф Норт Каролина Эт Чепел Хилл |
Оптимизированные гены aga и экспрессионные кластеры и их применение
|
BR112020012336A2
(pt)
|
2017-12-19 |
2021-03-30 |
Akouos, Inc. |
Administração de anticorpos terapêuticos mediada por aav para o ouvido interno
|
EA202092362A1
(ru)
|
2018-04-03 |
2021-01-11 |
Страйдбайо, Инк. |
Вирусные векторы для нацеливания на ткани глаза
|
MX2020010466A
(es)
|
2018-04-03 |
2021-01-08 |
|
Vectores de virus que evitan anticuerpos.
|
KR20210006357A
(ko)
|
2018-04-03 |
2021-01-18 |
스트라이드바이오 인코포레이티드 |
항체-회피 바이러스 벡터
|
EP3814513A4
(de)
|
2018-06-28 |
2022-04-13 |
The University of North Carolina at Chapel Hill |
Optimierte cln5-gene und expressionskassetten sowie deren verwendung
|
US20210316012A1
(en)
|
2018-08-10 |
2021-10-14 |
The University Of North Carolina At Chapel Hill |
Optimized cln7 genes and expression cassettes and their use
|
PE20211596A1
(es)
|
2018-10-01 |
2021-08-18 |
Univ Pennsylvania |
Composiciones utiles para tratar la gangliosidosis gm1
|
EP3887392A1
(de)
|
2018-11-26 |
2021-10-06 |
Universitat Autònoma De Barcelona |
Gentherapie mit fibroblastenwachstumsfaktor 21 (fgf21)
|
US20230193315A1
(en)
|
2019-01-31 |
2023-06-22 |
Oregon Health & Science University |
Methods for using transcription-dependent directed evolution of aav capsids
|
WO2020160244A1
(en)
|
2019-02-01 |
2020-08-06 |
Uab Research Foundation |
Methods and compositions for il10 signaling antagonism
|
PE20211819A1
(es)
|
2019-02-22 |
2021-09-14 |
Univ Pennsylvania |
Virus adenoasociado recombinante para el tratamiento de la neurodegeneracion de inicio en adultos asociada a grn
|
US20220118108A1
(en)
|
2019-02-26 |
2022-04-21 |
The Trustees Of The University Of Pennsylvania |
Compositions useful in treatment of krabbe disease
|
KR20220011616A
(ko)
|
2019-03-21 |
2022-01-28 |
스트라이드바이오 인코포레이티드 |
재조합 아데노 관련 바이러스 벡터
|
US11779683B2
(en)
|
2019-04-08 |
2023-10-10 |
Loubert S. Suddaby |
Extended release immunomodulatory implant to facilitate bone morphogenesis
|
US11369473B2
(en)
|
2019-04-08 |
2022-06-28 |
Loubert S. Suddaby |
Extended release immunomodulatory implant to facilitate bone morphogenesis
|
EP3959227A1
(de)
|
2019-04-26 |
2022-03-02 |
The University of North Carolina at Chapel Hill |
Verfahren und zusammensetzungen für dualen glycanbindenden aav2,5-vektor
|
CN113891726A
(zh)
|
2019-05-31 |
2022-01-04 |
巴塞罗那自治大学 |
胰岛素基因疗法
|
EP3990030A1
(de)
|
2019-06-27 |
2022-05-04 |
Pfizer Inc. |
Verfahren zur behandlung von duchenne-muskeldystrophie mittels aav-mini-dystrophin-gentherapie
|
WO2021021674A1
(en)
|
2019-07-26 |
2021-02-04 |
Akouos, Inc. |
Methods of treating hearing loss using a secreted target protein
|
US20220280427A1
(en)
|
2019-09-06 |
2022-09-08 |
Generation Bio Co. |
Lipid nanoparticle compositions comprising closed-ended dna and cleavable lipids and methods of use thereof
|
EP4045525A1
(de)
|
2019-10-17 |
2022-08-24 |
Stridebio, Inc. |
Adeno-assoziierte virusvektoren zur behandlung der niemann-pick-krankheit vom typ c
|
BR112022007481A2
(pt)
|
2019-11-22 |
2022-07-12 |
Generation Bio Co |
Lipídios ionizáveis e composições de nanopartículas dos mesmos
|
KR20220112283A
(ko)
|
2019-12-10 |
2022-08-10 |
다케다 야쿠힌 고교 가부시키가이샤 |
Hunter 질환 치료용 아데노-연합된 바이러스 벡터
|
JP2023520764A
(ja)
|
2020-03-24 |
2023-05-19 |
ジェネレーション バイオ カンパニー |
第ix因子治療薬を発現するための非ウイルス性dnaベクター及びその使用
|
JP2023520763A
(ja)
|
2020-03-24 |
2023-05-19 |
ジェネレーション バイオ カンパニー |
ゴーシェ治療薬を発現するための非ウイルス性dnaベクター及びその使用
|
MX2022014204A
(es)
|
2020-05-13 |
2023-04-14 |
Akouos Inc |
Composiciones y metodos para tratar la perdida auditiva asociada al gen slc26a4.
|
JP2023528590A
(ja)
|
2020-05-26 |
2023-07-05 |
ウニベルシダッド アウトノマ デ バルセロナ |
中枢神経系障害に対する線維芽細胞増殖因子21(fgf21)遺伝子治療
|
EP4200429A1
(de)
|
2020-08-24 |
2023-06-28 |
The Trustees of The University of Pennsylvania |
Virale vektoren zur codierung von glp-1-rezeptoragonistenfusionen und verwendungen davon bei der behandlung von stoffwechselerkrankungen
|
MX2023002364A
(es)
|
2020-08-26 |
2023-05-22 |
Univ Pennsylvania |
Virus adenoasociado recombinante para el tratamiento de la neurodegeneración iniciada en adultos asociada a grn.
|
US11225508B1
(en)
|
2020-09-23 |
2022-01-18 |
The University Of North Carolina At Chapel Hill |
Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
|
EP4225382A2
(de)
|
2020-10-07 |
2023-08-16 |
Asklepios Biopharmaceutical, Inc. |
Therapeutische adeno-assoziierte virusverabreichung von fkutin-verwandtem protein (fkrp) zur behandlung von dystroglycanopathie. erkrankungen mit gliedmassengürtel 21
|
US20230364206A1
(en)
|
2020-10-07 |
2023-11-16 |
Regenxbio Inc. |
Gene therapy for ocular manifestations of cln2 disease
|
WO2022082109A1
(en)
|
2020-10-18 |
2022-04-21 |
The Trustees Of The University Of Pennsylvania |
Improved adeno-associated virus (aav) vector and uses therefor
|
CN116490514A
(zh)
|
2020-10-28 |
2023-07-25 |
北卡罗来纳-查佩尔山大学 |
用于双重聚糖结合aav2.5载体的方法和组合物
|
WO2022093769A1
(en)
|
2020-10-28 |
2022-05-05 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav2.5 vector
|
WO2022094078A1
(en)
|
2020-10-28 |
2022-05-05 |
The Trustees Of The University Of Pennsylvania |
Compositions useful in treatment of rett syndrome
|
TW202233844A
(zh)
|
2020-10-29 |
2022-09-01 |
賓州大學委員會 |
Aav衣殼及含有其之組成物
|
EP4255570A1
(de)
|
2020-12-01 |
2023-10-11 |
Akouos, Inc. |
Anti-vegf-antikörperkonstrukte und zugehörige verfahren zur behandlung von vestibulärem schwannoma-assoziierten symptomen
|
IL303236A
(en)
|
2020-12-01 |
2023-07-01 |
Univ Pennsylvania |
New compounds with specific tissue-targeting motifs and preparations containing them
|
MX2023007800A
(es)
|
2020-12-29 |
2023-07-11 |
Akouos Inc |
Composiciones y metodos para tratar la perdida de audicion y/o la perdida de vision asociada a clrn1.
|
TW202242124A
(zh)
|
2021-01-14 |
2022-11-01 |
美商史崔德生物公司 |
靶向t細胞之aav載體
|
CA3206590A1
(en)
|
2021-01-30 |
2022-08-04 |
Maria Fatima Bosch Tubert |
Gene therapy for monogenic diabetes
|
EP4284335A1
(de)
|
2021-02-01 |
2023-12-06 |
RegenxBio Inc. |
Gentherapie für neuronale ceroid-lipofuscinosen
|
KR20230150836A
(ko)
|
2021-02-26 |
2023-10-31 |
다케다 야쿠힌 고교 가부시키가이샤 |
파브리병 치료를 위한 조성물 및 방법
|
JP2024515612A
(ja)
|
2021-04-12 |
2024-04-10 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
球脊髄性筋萎縮症(sbma)の治療に有用な組成物
|
JP2024515626A
(ja)
|
2021-04-16 |
2024-04-10 |
アスクレピオス バイオファーマシューティカル, インコーポレイテッド |
血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドaavビリオン
|
JP2024517427A
(ja)
|
2021-04-20 |
2024-04-22 |
アンジャリウム バイオサイエンシズ エージー |
アミロ-α-1,6-グルコシダーゼ、4-α-グルカノトランスフェラーゼをコードするDNA分子の組成物、その作製の方法、及びその使用の方法
|
KR20240000580A
(ko)
|
2021-04-23 |
2024-01-02 |
유니버시티 오브 로체스터 |
레트로바이러스 인테그라제-Cas 융합 단백질을 이용한 직접 비상동 DNA 삽입에 의한 게놈 편집 및 치료 방법
|
EP4089171A1
(de)
|
2021-05-12 |
2022-11-16 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Rekombinante tert-codierende virale genome und vektoren
|
CN117642380A
(zh)
|
2021-06-14 |
2024-03-01 |
世代生物公司 |
阳离子脂质及其组合物
|
KR20240067112A
(ko)
|
2021-09-30 |
2024-05-16 |
아카우오스, 인크. |
Kcnq4-연관 청력손실을 치료하기 위한 조성물 및 방법
|
WO2023056399A1
(en)
|
2021-10-02 |
2023-04-06 |
The Trustees Of The University Of Pennsylvania |
Novel aav capsids and compositions containing same
|
TW202340467A
(zh)
|
2022-01-10 |
2023-10-16 |
賓州大學委員會 |
有用於治療c9orf72介導之病症之組成物及方法
|
WO2023135273A2
(en)
|
2022-01-14 |
2023-07-20 |
Anjarium Biosciences Ag |
Compositions of dna molecules encoding factor viii, methods of making thereof, and methods of use thereof
|
WO2023147304A1
(en)
|
2022-01-25 |
2023-08-03 |
The Trustees Of The University Of Pennsylvania |
Aav capsids for improved heart transduction and detargeting of liver
|
AR128422A1
(es)
|
2022-02-02 |
2024-05-08 |
Akouos Inc |
Construcciones de anticuerpos anti-vegf y métodos relacionados para el tratamiento de los síntomas asociados al schwannoma vestibular
|
WO2023150687A1
(en)
|
2022-02-04 |
2023-08-10 |
Ginkgo Bioworks, Inc. |
Recombinant adeno-associated virus vectors, and methods of use thereof
|
WO2023187728A1
(en)
|
2022-04-01 |
2023-10-05 |
Takeda Pharmaceutical Company Limited |
Gene therapy for diseases with cns manifestations
|
WO2023196893A1
(en)
|
2022-04-06 |
2023-10-12 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating her2 positive metastatic breast cancer and other cancers
|
WO2024015966A2
(en)
|
2022-07-15 |
2024-01-18 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav having aav clade d and clade e capsids and compositions containing same
|
WO2024040222A1
(en)
|
2022-08-19 |
2024-02-22 |
Generation Bio Co. |
Cleavable closed-ended dna (cedna) and methods of use thereof
|
WO2024042485A1
(en)
|
2022-08-25 |
2024-02-29 |
Takeda Pharmaceutical Company Limited |
Composition for use in the treatment of fabry disease
|
WO2024052413A1
(en)
|
2022-09-07 |
2024-03-14 |
Universitat Autònoma De Barcelona |
Beta-hexosaminidase vectors
|
WO2024105638A1
(en)
|
2022-11-18 |
2024-05-23 |
Jcr Pharmaceuticals Co., Ltd. |
Recombinant aav vectors and methods for treatment of hunter syndrome
|
WO2024124019A2
(en)
|
2022-12-07 |
2024-06-13 |
Ginkgo Bioworks, Inc. |
Aav vectors targeting hematopoietic stem cells
|